Skip to main content
Premium Trial:

Request an Annual Quote

Cigna Using Telegenomics Services From Genome Medical

NEW YORK (GenomeWeb) -- Telegenomics technology company Genome Medical has begun providing genetic counseling services for insurer Cigna as of Oct. 1.

Genome Medical employs a team of more than 40 genetics experts and providers who conduct telehealth consultations in the areas of primary care, cancer, cardiovascular conditions, reproductive health, pediatrics, and pharmacogenetics. These experts can evaluate and make care decision for patients, and facilitate peer-to-peer consultations for providers.

"Adding Genome Medical to our genetic counseling program expands access for our customers and contracted care providers to a highly-specialized nationwide practice of credentialed, in-network and certified genetic counselors," Jeffrey Hankoff, Cigna's medical director, said in a statement.

Genome Medical CEO Lisa Alderson lauded Cigna for being innovative in its decision to incorporate the company’s telegenomics services. "Cigna's selection of Genome Medical demonstrates the importance of making genetic expertise and genomic services an integrated part of how patients receive care, and providers deliver it," Alderson said.

Headquartered in South San Francisco, Genome Medical has financial backing from Canaan Partners, GE Ventures, Illumina Ventures, Kaiser Permanente Ventures, and HealthInvest Equity Partners. In January, the firm said it closed a funding round worth $11 million and announced the launch of several programs aimed at helping employer groups offer genetics services and physician-guided genetic testing to their employees. At the time, the company said it had raised $23 million to date.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.